Yoshimichi Tanaka
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 16
- Endometriosis Research and Treatment 8
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 18
- Uterine Myomas and Treatments 13
- Cancer Research top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 6
-
- Cervical Cancer and HPV Research 5
-
- Estrogen and related hormone effects 5
-
- Metastasis and carcinoma case studies 3
- Co-authors
- Masahide OhmichiYoshito TeraiSatoshi TsunetohSatoe FujiwaraMasanori KanemuraTomohito TanakaAkiko TanabeHiroshi Kawaguchi
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Yoshimichi Tanaka
42 papers receiving 835 citations
Peers
Comparison fields: 5 of 79
- Reproductive Medicine 280
- Obstetrics and Gynecology 198
- Cancer Research 194
- Oncology 269
- Molecular Biology 350
Countries citing papers authored by Yoshimichi Tanaka
This map shows the geographic impact of Yoshimichi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimichi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimichi Tanaka more than expected).
Fields of papers citing papers by Yoshimichi Tanaka
This network shows the impact of papers produced by Yoshimichi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimichi Tanaka. The network helps show where Yoshimichi Tanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshimichi Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 0 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 9 | |
| 7 | 2018 | 12 | |
| 8 | 2017 | 86 | |
| 9 | 2017 | 18 | |
| 10 | 2017 | 12 | |
| 11 | 2015 | 15 | |
| 12 | 2013 | 16 | |
| 13 | 2013 | 2 | |
| 14 | 2013 | 74 | |
| 15 | 2013 | 15 | |
| 16 | 2012 | 68 | |
| 17 | 2012 | 16 | |
| 18 | 2012 | 2 | |
| 19 | 2009 | 10 | |
| 20 | 2007 | 9 |
About Yoshimichi Tanaka
Yoshimichi Tanaka is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 45 papers that have together received 850 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (18 papers), Ovarian cancer diagnosis and treatment (16 papers), Uterine Myomas and Treatments (13 papers), Endometriosis Research and Treatment (8 papers), Cancer Cells and Metastasis (6 papers), Cervical Cancer and HPV Research (5 papers), Estrogen and related hormone effects (5 papers) and Metastasis and carcinoma case studies (3 papers). The work is most often cited by research in Reproductive Medicine (280 citations), Obstetrics and Gynecology (198 citations) and Cancer Research (194 citations). Yoshimichi Tanaka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Masahide Ohmichi, Yoshito Terai, Satoshi Tsunetoh, Satoe Fujiwara, Masanori Kanemura, Tomohito Tanaka, Akiko Tanabe, Hiroshi Kawaguchi, Masaaki Takai and K Ashihara. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.